Ventyx Biosciences, Inc.

NASDAQ:VTYX

1.2 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -135.122-192.962-108.426-83.746-28.174-4.327
Depreciation & Amortization 1.3480.9410.470.0300
Deferred Income Tax 000000
Stock Based Compensation 22.93128.58816.572.730.0450.198
Change In Working Capital -10.5635.806-5.1574.0160.8120.591
Accounts Receivables 000000
Inventory 000000
Accounts Payables -2.644-0.7451.6132.4430.5910.361
Other Working Capital -7.9196.551-6.771.5730.2210.23
Other Non Cash Items -9.467-8.895-2.22838.3221.1220.896
Operating Cash Flow -130.873-166.522-98.771-38.65-6.195-2.642
Investing Activities:
Investments In Property Plant And Equipment -0.241-0.514-0.275-0.26200
Acquisitions Net 000.0751.89900
Purchases Of Investments -283.65-272.271-347.236-232.50200
Sales Maturities Of Investments 268.385373.725272.5816.500
Other Investing Activites 00-0.075-0.21600
Investing Cash Flow -15.506100.94-74.931-214.36500
Financing Activities:
Debt Repayment 0000.456.1282.95
Common Stock Issued 95.04648.408165.398158.8150.0020.001
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 27.0694.9212.374164.2860.0020.001
Financing Cash Flow 122.11553.329167.772323.5516.132.951
Other Information:
Effect Of Forex Changes On Cash -0.055-0.012-0.0420.01100
Net Change In Cash -24.319-12.265-5.97270.547-0.0650.309
Cash At End Of Period 28.23552.55464.81970.7910.2440.309